Clinical trial
A Study to Evaluate the Pharmacokinetics, Efficacy and Safety of Intravenous…
NCT02277444 · Janssen Research & Development, LLC, Industry · Completed
Key facts
| NCT number | NCT02277444 |
|---|---|
| Title | A Study to Evaluate the Pharmacokinetics, Efficacy and Safety of Intravenous Golimumab in Pediatric Participants With Active Polyarticular Course Juvenile Idiopathic Arthritis Despite Methotrexate Therapy |
| Official title | A Multicenter, Open-Label Trial of Intravenous Golimumab, a Human Anti-TNFα Antibody, in Pediatric Subjects With Active Polyarticular Course Juvenile Idiopathic Arthritis Despite Methotrexate Therapy |
| Acronym | GO-VIVA |
| Lead sponsor | Janssen Research & Development, LLC, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Arthritis, Juvenile |
| Intervention type | Drug |
| Interventions | Golimumab, Methotrexate |
| Enrollment | 130 |
| Start date | Dec 22, 2014 |
| Primary completion | Jul 9, 2018 |
| Completion | Sep 27, 2024 |
| First posted | Oct 29, 2014 |
| Last update posted | Nov 14, 2025 |
| Countries | Argentina, Brazil, Canada, Chile, Israel, Mexico, Russia, South Africa, United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: